Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin-based therapies.
Saved in:
| Title: | Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin-based therapies. |
|---|---|
| Authors: | Serra I; Department of Physiology and Pharmacology 'V. Erspamer', Sapienza University of Rome, Rome, Italy.; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy., Bisconti E; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy., Vergara D; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy., Giudetti AM; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy., Vari F; Department of Physiology and Pharmacology 'V. Erspamer', Sapienza University of Rome, Rome, Italy.; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2026 May 17. Date of Electronic Publication: 2026 May 17. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42144898 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin-based therapies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Serra+I%22">Serra I</searchLink>; Department of Physiology and Pharmacology 'V. Erspamer', Sapienza University of Rome, Rome, Italy.; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy.<br /><searchLink fieldCode="AU" term="%22Bisconti+E%22">Bisconti E</searchLink>; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy.<br /><searchLink fieldCode="AU" term="%22Vergara+D%22">Vergara D</searchLink>; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy.<br /><searchLink fieldCode="AU" term="%22Giudetti+AM%22">Giudetti AM</searchLink>; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy.<br /><searchLink fieldCode="AU" term="%22Vari+F%22">Vari F</searchLink>; Department of Physiology and Pharmacology 'V. Erspamer', Sapienza University of Rome, Rome, Italy.; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, Lecce, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227502536%22">British journal of pharmacology</searchLink> [Br J Pharmacol] 2026 May 17. <i>Date of Electronic Publication: </i>2026 May 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7502536 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5381 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071188%22">00071188 </searchLink><i>NLM ISO Abbreviation: </i>Br J Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42144898 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bph.70511 Languages: – Code: eng Text: English Titles: – TitleFull: Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin-based therapies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Serra I – PersonEntity: Name: NameFull: Bisconti E – PersonEntity: Name: NameFull: Vergara D – PersonEntity: Name: NameFull: Giudetti AM – PersonEntity: Name: NameFull: Vari F IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 05 Text: 2026 May 17 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5381 Titles: – TitleFull: British journal of pharmacology Type: main |
| ResultId | 1 |